People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

DBV Technologies reports positive Phase 3 data for its VIASKIN Peanut patch in children, supporting a planned U.S. BLA filing ...

The ACIP has been accused of cherry-picking data on side effects – attempting to perpetuate a debunked link between the shots ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

A recent study revealed that antiviral treatment for herpes worsened cognitive decline in early Alzheimer's patients, challenging the viral hypothesis of the disease.

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

Dry cabin air, exposure to germs and long hours at high altitudes — how do you prevent getting sick while flying? We asked a ...

Dry cabin air, exposure to germs and long hours at high altitudes — how do you prevent getting sick while flying? We asked a ...

GSK plc announced the marketing authorisation of Exdensur (depemokimab) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Exdensur is now approved in two indications: ...

Lerodalcibep is currently under regulatory review by both the European Medicines Agency (EMA).‌ In Greater China, Biologics License Application (BLA) submission is expected in 1H 2026, with the ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Optimized Gel Formulation Demonstrates Clinical Success in Third Cohort of Patients PRINCETON, N.J., Dec. 17, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ...